GeneMatrix Inc.
Research GeneMatrix Inc. (109820.KQ) on Bullrun: market cap KRW 30.92B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker109820.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyKRW
- Market capKRW 30.92B
- Financial periodQ2 2026
- RevenueKRW 2.91B
- Net incomeKRW 688.76M
- Free cash flowKRW 1.03B
- Gross margin62.7%
Valuation Snapshot
latest market cap is KRW 30.92B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 30.92B | n/a | n/a | n/a |
Dividend history
About GeneMatrix Inc.
GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics. The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections; vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement and treatment.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GeneMatrix Inc.'s market cap?
GeneMatrix Inc.'s market capitalization is KRW 30.92B.
What does GeneMatrix Inc. do?
GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics. The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections; vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement and treatment. It also provides biochemical diagnostics, such as special chemistry and general chemistry, that includes semi and full auto analyer, and calibrators and controls.